// App-Quantinova.ai

1104-081 : TEMPORAL COURSE OF NEOINTIMAL HYPERPLASIA FOLLOWING DRUG ELUTING STENT IMPLANTATION AS ASSESSED BY OPTICAL COHERENCE TOMOGRAPHY

Researchers

Presenter

  • Haris Riaz

Principal Investigators

  • Muhammad Shahzeb Khan

  • Talha Riaz

  • Mehak Idrees

  • Sajjad Gul

  • Joshua Clevenger

  • Eoin Donnellan

  • Samir Kapadia

Medical Centers

  • Dow University of Health Sciences, Karachi, Pakistan,

Locations

  • Pakistan

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Neoatherosclerosis

  • Venous thrombosis

  • Restenosis

Biomarkers

  • N/A

Drug/Treatment

  • Paclitaxel

  • Rapacan

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved